Predictions
Siemens Healthineers AG
Start price
Target price
Perf. (%)
€52.60
19.02.22
19.02.22
€60.00
19.02.23
19.02.23
-4.94%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Siemens Healthineers AG
Start price
Target price
Perf. (%)
€52.60
19.02.22
19.02.22
€60.00
19.02.23
19.02.23
-4.94%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
HelloFresh SE
Start price
Target price
Perf. (%)
€48.32
19.02.22
19.02.22
€27.00
19.02.23
19.02.23
-55.07%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€182.24
19.02.22
19.02.22
€200.00
19.02.23
19.02.23
-9.80%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
Rising EBIT margin expected
Valuable balance sheet
Stable Large shareholder and/or long term investor
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€182.24
19.02.22
19.02.22
€200.00
19.02.23
19.02.23
-9.80%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
Rising EBIT margin expected
Valuable balance sheet
Stable Large shareholder and/or long term investor
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€182.24
19.02.22
19.02.22
€200.00
19.02.23
19.02.23
-9.80%
20.02.23
20.02.23
Could be worthwhile Investment >10% per year
Rising EBIT margin expected
Valuable balance sheet
Stable Large shareholder and/or long term investor
Deutsche Lufthansa AG
Start price
Target price
Perf. (%)
€7.54
19.02.22
19.02.22
-
19.02.23
19.02.23
29.35%
20.02.23
20.02.23
Could be very worthwhile Investment >20% year
McPhy Energy S.A.
Start price
Target price
Perf. (%)
€13.43
23.10.22
23.10.22
€12.00
23.10.23
23.10.23
-4.21%
18.02.23
18.02.23
Could be worthwhile Investment >10% per year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.87
05.02.23
05.02.23
-
05.02.24
05.02.24
-10.07%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.04
07.02.23
07.02.23
€1.00
07.02.24
07.02.24
-7.35%
18.02.23
18.02.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€1.58
07.02.23
07.02.23
€1.00
07.02.24
07.02.24
-5.06%
18.02.23
18.02.23
Probably not worthwhile Investment
Below average Management
Bad culture
Orpea Nom.
Start price
Target price
Perf. (%)
€2.36
07.02.23
07.02.23
€4.00
07.02.24
07.02.24
9.32%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€2.80
07.02.23
07.02.23
€5.00
07.02.24
07.02.24
-39.31%
18.02.23
18.02.23
Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
EBIT decline/stagnation expected
Aixtron SE
Start price
Target price
Perf. (%)
€24.78
11.02.23
11.02.23
€30.00
11.02.24
11.02.24
4.56%
18.02.23
18.02.23
Leading role in innovation
Some uniques
Aixtron SE
Start price
Target price
Perf. (%)
€24.78
11.02.23
11.02.23
€30.00
11.02.24
11.02.24
4.56%
18.02.23
18.02.23
Leading role in innovation
Some uniques